Contemporary Hormonal Contraception and the Risk of Breast Cancer
- 7 December 2017
- journal article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 377 (23), 2228-2239
- https://doi.org/10.1056/nejmoa1700732
Abstract
Little is known about whether contemporary hormonal contraception is associated with an increased risk of breast cancer.Keywords
This publication has 36 references indexed in Scilit:
- Contraceptive use in the Nordic countriesActa Obstetricia et Gynecologica Scandinavica, 2016
- Oral contraception in Denmark 1998-2010Acta Obstetricia et Gynecologica Scandinavica, 2012
- Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal WomenThe New England Journal of Medicine, 2009
- Progestins and breast cancerGynecological Endocrinology, 2007
- Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal WomenJAMA, 2003
- Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.American Journal of Epidemiology, 2000
- Progestins and menopause: epidemiological studies of risks of endometrial and breast cancerSteroids, 2000
- Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus ProgestinJNCI Journal of the National Cancer Institute, 2000
- Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer RiskJAMA, 2000
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996